Ganoderic acid D2

• UNSPSC Description:

  Ganoderic acid D2 (compound 27) is a triterpenoid isolated from Ganoderma lucidum. Ganoderic acid D2 has anticancer, anti-inflammatory and antioxidative activity[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ganoderic-acid-d2.html

• Purity:

  99.18

• Solubility:

  DMSO : 25 mg/mL (ultrasonic)

• Smiles:

  C[C@@H]([C@H]1CC([C@]2(C)[C@]1(C)[C@H](O)C(C3=C2[C@@H](O)C[C@@H]4[C@]3(C)CCC(C4(C)C)=O)=O)=O)CC(CC(C(O)=O)C)=O

• Molecular Weight:

  530.65

• References & Citations:

  [1]Xiao-Yu Guo, et al. Identification of major compounds in rat bile after oral administration of total triterpenoids of Ganoderma lucidum by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal. 2012 Apr 7;63:29-39.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  97653-94-6